McLaughlin, Kelsey; Lytvyn, Yuliya; Luca, Mary Clare et al.
Repeated daily dosing with sildenafil provides sustained protection from endothelial dysfunction caused by ischemia and reperfusion: a human in vivo studyAMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY. Bd. 307. H. 6. 2014 S. H888-H894
Keller, Karsten; Beule, Johannes; Schulz, Andreas et al.
Right ventricular dysfunction in hemodynamically stable patients with acute pulmonary embolismTHROMBOSIS RESEARCH. Bd. 133. H. 4. 2014 S. 555-559
von Bardeleben, R. S.; Mohr-Kahaly, S.; Kreitner, K. -F. et al.
Role of imaging modalities in the diagnosis of acute coronary syndrome (ACS): echocardiography, MRI, and CTDEUTSCHE MEDIZINISCHE WOCHENSCHRIFT. Bd. 139. 2014 S. S13-S16
Schmidt, F. P.; Kreuder, K.; Kolle, K. et al.
Severe adverse effects of nocturnal aircraft noise on endothelial function in patients with or being at risk for cardiovascular diseaseEUROPEAN HEART JOURNAL. Bd. 35. 2014 S. 561-561
Rostock, Thomas; Konrad, Torsten; Theis, Cathrin
Simplifying atrial fibrillation ablation: How far can we go?HEART RHYTHM. Bd. 11. H. 1. 2014 S. 15-16
Schmidt, F. P.; Peivandi, A. A.; Kohnen, W. et al.
Surgery for acquired cardiovascular disease: antiseptic treatment of contaminated vein graftsJOURNAL OF CARDIOVASCULAR SURGERY. Bd. 55. H. 2. 2014 S. 271-277
Keller, K.; Prochaska, J.; Coldewey, M. et al.
The association of deep venous thrombosis with atherosclerosis depends on a concomitant history of pulmonary embolismEUROPEAN HEART JOURNAL. Bd. 35. 2014 S. 991-992
Fuchs, T; Puellmann, K; Emmert, A et al.
The macrophage-TCRaß is a cholesterol-responsive combinatorial immune receptor and implicated in atherosclerosisBiochem Biophys Res Comm. Bd. Nov. H. 21. 2014 S. S0006-291X
Schildknecht, S.; Weber, A.; Gerding, H. R. et al.
The NOX1/4 Inhibitor GKT136901 as Selective and Direct Scavenger of PeroxynitriteCURRENT MEDICINAL CHEMISTRY. Bd. 21. H. 3. 2014 S. 365-376
Oelze, Matthias; Kroeller-Schoen, Swenja; Welschof, Philipp et al.
The Sodium-Glucose Co-Transporter 2 Inhibitor Empagliflozin Improves Diabetes-Induced Vascular Dysfunction in the Streptozotocin Diabetes Rat Model by Interfering with Oxidative Stress and GlucotoxicityPLOS ONE. Bd. 9. H. 11. 2014